Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Clinical trial NCT00276783 · UNKNOWN

Trial details

NCT number: NCT00276783
Sponsor: Northwestern University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Lymphoma Metastatic Cancer

Start date: 2005-11-01
Primary completion: 2022-12-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.